James Ravitz

James Ravitz

Wilson Sonsini Goodrich & Rosati

Contact
View Bio
RSS

Latest Posts › 21st Century Cures Act

Share:

A Preliminary Evaluation of the RMAT Designation's Effect on Publicly Traded Company Stock Price

The 21st Century Cures Act created the Regenerative Medicine Advanced Therapy (RMAT) designation in recognition of the growing importance of regenerative medical therapies. An RMAT designation conveys significant regulatory...more

12/17/2019  /  21st Century Cures Act , Clinical Trials , Food and Drug Administration (FDA) , Investigational New Drug Application (IND) , Pharmaceutical Industry , Prescription Drugs , Publicly-Traded Companies , Regenerative Medicine , Stock Prices
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide